First Wilshire Securities Management Inc Soligenix, Inc. Transaction History

First Wilshire Securities Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 17, 2021	BUY	$1.26 - $2.75 $126,000 - $275,000	100,000 Added 40.0%	350,000 $448,000
Q3 2020 Nov 16, 2020	BUY	$1.7 - $2.61 $85,000 - $130,500	50,000 Added 25.0%	250,000 $448,000
Q2 2020 Aug 14, 2020	BUY	$1.36 - $2.26 $136,000 - $225,999	100,000 Added 100.0%	200,000 $422,000
Q1 2020 May 15, 2020	BUY	$1.42 - $3.34 $142,000 - $334,000	100,000 New	100,000 $168,000

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $102M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of First Wilshire Securities Management Inc, based on Form 13F filings with the SEC.

Stay updated on First Wilshire Securities Management Inc with notifications on news.